Despite anti-snake venom (ASV) availability, India's high snakebite mortality persists due to a flawed syndromic diagnosis approach, lack of rapid venom detection kits, and gaps in clinical infrastructure. This highlights a critical public health failure where agricultural workers and children are most vulnerable.
Exam Lens
Quick Exam Facts From News
1-Minute Revision
- ›India's Global Snakebite Share: Nearly 50%
- ›Non-Venomous Snakebite Cases: About 70%
- ›Target this Data: India accounts for nearly 50% of global snakebites.
- ›Target this Nodal Body: Indian Council of Medical Research (ICMR) - flagged the syndromic approach.
- ›Target this Programme: SARPA (Snake Awareness, Rescue, and Protection) programme in Kerala.
Mastered this topic? Test your knowledge with a full MCQ quiz.
Practice exam-style questions, track your score, and strengthen your recall.